News & media

Gillian Corbett

A current overview of medications in the treatment of CLL in New Zealand

A talk presented to the CLL Advocates NZ Board of Trustees on 7 May 2020 by Dr Gillian Corbett…

Continue reading

Study Findings Support Long-Term Efficacy and Safety of Acalabrutinib in R/R CLL

Long-term follow-up of a phase 1/2 study demonstrated durable efficacy and safety of acalabrutinib…

Continue reading

Coronavirus: Separating Fact From Fiction for CLL Patients

“We're learning every day, and we're modifying and adjusting based on what we learn,” says Dr.…

Continue reading

COVID-19’s Impact on How Patients with CLL, Myeloma Have Received Treatment

In the first installment of CURE®’s inaugural webinar series, “Hear from the Experts: COVID-19 &…

Continue reading

How COVID-19 Has Impacted Clinical Trials for Chronic Lymphocytic Leukemia

The COVID-19 Pandemic has changed immediate treatment for patients with chronic lymphocytic…

Continue reading

New Research Shows Real-World Track Record of Common CLL Therapies

A new study based on treatment of patients with chronic lymphocytic leukemia (CLL) in mostly…

Continue reading

Neil Graham video

CLLANZ calls for home-based treatment for CLL patients during COVID pandemic

We’ve been concerned about the current COVID-related risks to CLL patients who may be delaying…

Continue reading

How it feels to be in intensive care with COVID-19 – a survivor with CLL

"I had never felt so alone in all my life," writes coronavirus survivor Robin Bowler in his…

Continue reading

New Score Predicts When Patients With CLL Should Start Treatment

Most patients with chronic lymphocytic leukemia (CLL) are diagnosed with early stage disease and…

Continue reading

Patient With CLL May Have Had Longer COVID-19 Incubation Period

A case report out of China suggested that clinical and biochemical data of COVID-19 might have been…

Continue reading

Coronavirus disease (COVID-19) and CLL patients

CLL Advocates Network is closely monitoring the strategies being implemented in various countries…

Continue reading

The squeeze on healthcare in locked-down New Zealand

Medical centres across the country are condensing services, moving online and ushering in pandemic…

Continue reading

How COVID-19 is Impacting Patients with Chronic Lymphocytic Leukemia

As the new coronavirus (COVID-19) continues to spread around the world, concerns about how the…

Continue reading

An open letter to the Prime Minister of New Zealand

Urgently fund medicines to save the lives of our most vulnerable, defenceless citizens, ie those…

Continue reading

Covid 19 coronavirus: Pharmac eases restrictions on cancer drugs during Covid-19 pandemic

Pharmac will ease restrictions on at least nine cancer drugs, including keytruda for the treatment…

Continue reading

‘It is daunting to be told how personally dangerous coronavirus is’

UK reporter Sam O'Neill: I am part of the group with what are so often blandly referred to as…

Continue reading

Coronavirus: how Asian countries acted while the west dithered

In Hong Kong and Taiwan, deaths are in single figures. But Europe gambled on a containment…

Continue reading

Coronavirus in NZ: How to self-isolate – Kiwi diagnosed with cancer shares advice

A Kiwi diagnosed with cancer has shared advice on how to self-isolate while living with others and…

Continue reading

Coronavirus: how to self-isolate

What to do if you have symptoms of Covid-19, have travelled to a badly affected area, or have been…

Continue reading

COVID-19 and CLL

This is a collection of practical tips gathered from this forum over the years, to help us live…

Continue reading

30 tips for living well with CLL (an update of “Coping Strategies” and “Things we can do…”)

This is a collection of practical tips gathered from this forum over the years, to help us live…

Continue reading

Single-cell sequencing of CLL therapy: Shared genetic program, patient-specific execution

Chronic lymphocytic leukemia (CLL) is the most common form of blood cancer (leukemia) in the…

Continue reading

More Specific BTK Inhibitor Shows High Relative Rates of Response in CLL

In a phase 3 trial, acalabrutinib, a second-generation Bruton’s tyrosine kinase (BTK), provided a…

Continue reading

Neil Graham video

Slides from Edinburgh

The combination of two targeted therapies — ibrutinib (Imbruvika, Pharmacyclics/Janssen) and…

Continue reading

Ibrutinib and Venetoclax Combo ‘Impressive’ in Front-Line CLL

The combination of two targeted therapies — ibrutinib (Imbruvika, Pharmacyclics/Janssen) and…

Continue reading

RIP Clive James

Clive James, the Australian wit, broadcaster and poet died last Sunday at the age of 80, ten years…

Continue reading

Slide highlights from CLL Horizons

This is a series of slides from the recent conference, CLL Horizons, in Edinburgh that may be of…

Continue reading

Most anticipated studies on chronic lymphocytic leukemia at ASH

In this Guest Commentary, Ryan W. Jacobs, MD, principal investigator of clinical trials for chronic…

Continue reading

Cancer Control Agency open, Prime Minister hails Blair Vining’s ‘tireless advocacy’

The Prime Minister has acknowledged Blair Vining's "tireless advocacy" as the new independent…

Continue reading

Petition for Patient Voice Aotearoa: Reform Pharmac and double the Pharmac budget

There are issues involving Pharmac and how they fund medicines - Pharmac does not adopt…

Continue reading